Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation system

BelluscuraNews

LONDON, UK, PLANO, TX AND WAYNESBURG, PA, March 13, 2020.  Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel modular portable oxygen enrichment ventilation systems for treating patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS) brought on by such diseases as COVID-19.

The latest patent application covers devices and systems for treating people suffering from COPD and ARDS including patients suffering from the recent coronavirus, COVID-19.  The primary cause of death from respiratory viruses like the coronavirus and influenza, are the result of the fluids accumulating inside the alveoli (the tiny air sacs of the lungs) which ultimately leads to the failure of the transfer of oxygen to and carbon dioxide out of the blood.  The current primary treatment for ARDS is oxygen therapy along with ventilator support.

Belluscura and Separation Design are rapidly designing and developing next generation, cost-effective, portable oxygen enrichment and ventilation technology to treat COPD and ARDS patients.

Commenting on the patenting activities, Bob Rauker, CEO of Belluscura, said: “We are very excited about our next generation oxygen technologies.  With the launch this year of our first product, the X-PLOR™ portable oxygen concentrator, into the respiratory treatment field where over 250 million people suffer from chronic obstructive pulmonary disease (COPD), the third leading cause of death, it is critical that we continue to innovate into the ever-expanding oxygen therapy market”.  Doug Galbraith, CEO of Separation Design, lead inventor on over 12 oxygen enrichment patents, states, “We need to continue developing cost-effective respiratory solutions to meet the healthcare demands of the future.”

Background to Belluscura

Belluscura (www.belluscura.com) was established in the UK in December 2015 with the goal of enriching life through inno2vation.

Separation Design Group (www.Separationdesign.com) is a research and product development firm established in 2003 and located in Waynesburg, Pennsylvania,

This Press Release contains forward-looking statements that involve substantial risks and uncertainties, and actual results and developments may differ materially from those expressed or implied by these statements. These forward-looking statements are statements regarding the Company’s intentions, beliefs or current expectations concerning, among other things, the Company’s results of operations, financial condition, prospects, growth, strategies and the industry in which the Company operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.  These forward-looking statements speak only as of the date of this Press Release and the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of this Press Release.

www.belluscura.com

Contact:               Investor Relations

Name:                  CEO

e-mail:                  investor@belluscura.com

phone:                 1-214-396-8313